Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015, Article ID 437298, 5 pages
http://dx.doi.org/10.1155/2015/437298
Case Report

Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature

1Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPaz, School of Medicina, Universidad Autónoma de Madrid, Paseo de la Castellana 261, 28046 Madrid, Spain
2Pediatric Hepatology Department, Hospital Universitario La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain
3Pathological Anatomy Department, Hospital Universitario La Paz, IdiPaz, Paseo de la Castellana 261, 28046 Madrid, Spain

Received 13 October 2014; Accepted 9 December 2014

Academic Editor: Seyed Mohsen Dehghani

Copyright © 2015 Hoi Y. Tong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Greenhill, S. Kollins, H. Abikoff et al., “Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 11, pp. 1284–1293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. L. L. Greenhill, “Stimulant medication treatment of children with attention deficit hyperactivity disorder,” in Attention Deficit Hyperactivity Disorder: State of Science. Best Practices, P. S. Jensen and J. R. Cooper, Eds., pp. 9–27, Civic Research Institute, Kingston, NJ, USA, 2002. View at Google Scholar
  3. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management et al., “ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/ hyperactivity disorder in children and adolescents,” Pediatrics, vol. 128, no. 5, pp. 1007–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Arcieri, E. A. P. Germinario, M. Bonati et al., “Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine,” Journal of Child and Adolescent Psychopharmacology, vol. 22, no. 6, pp. 423–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Martinez-Raga, C. Knecht, N. Szerman, and M. I. Martinez, “Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder,” CNS Drugs, vol. 27, no. 1, pp. 15–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. R. Goodman, “Hepatotoxicity due to methylphenidate hydrochloride,” New York State Journal of Medicine, vol. 72, no. 18, pp. 2339–2340, 1972. View at Google Scholar · View at Scopus
  7. E. L. Torres, V. G. del Valle, K. Pachkoria, R. Cueto, and M. I. Lucena, “Hepatotoxicidad por metilfenidato en el tratamiento del trastorno por déficit de atención con hiperactividad,” Casos Farmacoterápicos, vol. 3, no. 4, pp. 269–270, 2005. View at Google Scholar
  8. M. K. Bernhard, B. Hugle, and A. Merkenschlager, “Elevated liver enzymes under therapy with methylphenidate in a boy with T-cell leukemia,” Journal of Pediatric Neurology, vol. 7, no. 3, pp. 297–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Russmann, G. A. Kullak-Ublick, and I. Grattagliano, “Current concepts of mechanisms in drug-induced hepatotoxicity,” Current Medicinal Chemistry, vol. 16, no. 23, pp. 3041–3053, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Mehta, B. Murray, and T. A. LoIudice, “Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride,” Journal of Clinical Gastroenterology, vol. 6, no. 2, pp. 149–151, 1984. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Lewis, J. C. Iezzoni, and C. L. Berg, “Methylphenidate-induced autoimmune hepatitis,” Digestive Diseases and Sciences, vol. 52, no. 2, pp. 594–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Robert, R. P. DeMott, and R. C. James, “Adrenergic modulation of hepatotoxicity,” Drug Metabolism Reviews, vol. 29, no. 1-2, pp. 329–353, 1997. View at Google Scholar
  13. S. M. Roberts, R. D. Harbison, L. Roth, and R. C. James, “Methylphenidate-induced hepatotoxicity in mice and its potentiation by β-adrenergic agonist drugs,” Life Sciences, vol. 55, no. 4, pp. 269–281, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. T. E. Wilens, P. G. Hammerness, J. Biederman et al., “Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder,” The Journal of Clinical Psychiatry, vol. 66, no. 2, pp. 253–259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Nissen, “ADHD drugs and cardiovascular risk,” The New England Journal of Medicine, vol. 354, no. 14, pp. 1445–1448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Suzuki, E. M. Brunt, D. E. Kleiner et al., “The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury,” Hepatology, vol. 54, no. 3, pp. 931–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. García-Cortés, M. I. Lucena, R. J. Andrade, R. Camargo, and R. Alcántara, “Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity?” Annals of Pharmacotherapy, vol. 38, no. 9, pp. 1540–1541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Bénichou, “Criteria of drug-induced liver disorders. Report of an international consensus meeting,” Journal of Hepatology, vol. 11, no. 2, pp. 272–276, 1990. View at Google Scholar
  19. N. Mehta, L. Ozick, and E. Gbadehan, “Drug-induced hepatotoxicity,” Medscape reference, January 2013, http://emedicine.medscape.com/article/169814-overview.